Literature DB >> 25194429

Graves'-like orbitopathy: do not forget IgG4-related disease.

L Bartalena1, L Chiovato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25194429     DOI: 10.1007/s40618-014-0171-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  10 in total

Review 1.  IgG4-related disease.

Authors:  John H Stone; Yoh Zen; Vikram Deshpande
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

2.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.

Authors:  John H Stone; Arezou Khosroshahi; Vikram Deshpande; John K C Chan; J Godfrey Heathcote; Rob Aalberse; Atsushi Azumi; Donald B Bloch; William R Brugge; Mollie N Carruthers; Wah Cheuk; Lynn Cornell; Carlos Fernandez-Del Castillo; Judith A Ferry; David Forcione; Günter Klöppel; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Yasufumi Masaki; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant Sahani; Yasuharu Sato; Thomas Smyrk; James R Stone; Masayuki Takahira; Hisanori Umehara; George Webster; Motohisa Yamamoto; Eunhee Yi; Tadashi Yoshino; Giuseppe Zamboni; Yoh Zen; Suresh Chari
Journal:  Arthritis Rheum       Date:  2012-10

3.  Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum.

Authors:  Mollie Dahlgren; Arezou Khosroshahi; G Petur Nielsen; Vikram Deshpande; John H Stone
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

4.  Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis.

Authors:  Rodolfo Fonte; Barbara Pirali; Vitantonio Caramia; Rosa Dionisio; Sara Lodigiani; Luisella Sibilla; Mario Rotondi; Luca Chiovato
Journal:  Thyroid       Date:  2011-11-08       Impact factor: 6.568

5.  Intractable graves ophthalmopathy?

Authors:  Francisco Castillo; James A Garrity; Daniel J Kravitz
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

Review 6.  Prevalence and natural history of Graves' orbitopathy in the XXI century.

Authors:  E Piantanida; M L Tanda; A Lai; L Sassi; L Bartalena
Journal:  J Endocrinol Invest       Date:  2013-04-16       Impact factor: 4.256

7.  Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis.

Authors:  Yaqiong Li; Yanhua Bai; Zhiyan Liu; Takashi Ozaki; Emiko Taniguchi; Ichiro Mori; Koji Nagayama; Hirotoshi Nakamura; Kennichi Kakudo
Journal:  Pathol Int       Date:  2009-09       Impact factor: 2.534

8.  Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.

Authors:  M L Tanda; E Piantanida; L Liparulo; G Veronesi; A Lai; L Sassi; N Pariani; D Gallo; C Azzolini; M Ferrario; L Bartalena
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

Review 9.  Extrathyroidal manifestations of Graves' disease: a 2014 update.

Authors:  Luigi Bartalena; Vahab Fatourechi
Journal:  J Endocrinol Invest       Date:  2014-06-10       Impact factor: 4.256

10.  Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients.

Authors:  C A Tiegs-Heiden; L J Eckel; C H Hunt; F E Diehn; K M Schwartz; D F Kallmes; D R Salomão; T E Witzig; J A Garrity
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-13       Impact factor: 3.825

  10 in total
  7 in total

1.  Exophthalmos (Graves' orbitopathy) in an ancient sculpture.

Authors:  J Tassinari; A Sisti
Journal:  J Endocrinol Invest       Date:  2016-04-20       Impact factor: 4.256

2.  Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies.

Authors:  T Diana; C Wüster; M Kanitz; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2016-05-19       Impact factor: 4.256

Review 3.  Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.

Authors:  M Marinò; I Ionni; G Lanzolla; A Sframeli; F Latrofa; R Rocchi; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-11-05       Impact factor: 5.467

Review 4.  Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.

Authors:  Natacha Turck; Simone Eperon; Maria De Los Angeles Gracia; Aurélie Obéric; Mehrad Hamédani
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

5.  Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.

Authors:  P Perros; L Hegedüs; L Bartalena; C Marcocci; G J Kahaly; L Baldeschi; M Salvi; J H Lazarus; A Eckstein; S Pitz; K Boboridis; P Anagnostis; G Ayvaz; A Boschi; T H Brix; N Currò; O Konuk; M Marinò; A L Mitchell; B Stankovic; F B Törüner; G von Arx; M Zarković; W M Wiersinga
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

6.  IgG4-related disease in endocrine practice.

Authors:  Agata Rzepecka; Anna Babińska; Krzysztof Sworczak
Journal:  Arch Med Sci       Date:  2017-10-20       Impact factor: 3.318

Review 7.  Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Eliana Piantanida; Daniela Gallo; Adriana Lai; Maria Laura Tanda
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-30       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.